Macro- and microvascular function in habitually exercising systemic lupus erythematosus patients
- PMID: 24392783
- DOI: 10.3109/03009742.2013.846408
Macro- and microvascular function in habitually exercising systemic lupus erythematosus patients
Abstract
Objectives: Vascular dysfunction is commonly observed in systemic lupus erythematosus (SLE) patients and may explain the accelerated cardiovascular disease (CVD) risk. It is unknown whether physical activity influences vascular function in SLE patients. We aimed to determine whether habitually exercising SLE patients also demonstrate a reduction in vascular function.
Method: This study involved 41 young and middle-aged adults, including 15 healthy controls, 12 sedentary SLE patients, and 14 physically active SLE patients.
Results: Flow-mediated dilation (FMD), a measure of macrovascular function, was lower (3.6 ± 1.3 vs. 8.1 ± 1.2%; p < 0.05) and inflammatory markers [C-reactive protein (CRP), interleukin (IL)-12, and tumour necrosis factor (TNF)-α] were higher in sedentary SLE patients than in age-matched healthy controls (p < 0.05). Importantly, FMD and inflammatory markers were not different between physically active SLE patients and healthy controls. There were no group differences in skin reactive hyperaemia (RH) or minimal vascular resistance, both measures of microvascular function. Physically active SLE patients had lower intercellular adhesion molecule (ICAM)-1 concentrations and SLE disease activity scores than their sedentary peers. FMD was inversely associated with IL-6 and IL-10 (both p < 0.05).
Conclusions: Significant SLE-associated macrovascular dysfunction was absent in physically active SLE patients. Additionally, vascular function was associated with inflammatory markers, suggesting that the favourable influence of physical activity may be mediated by its effect on inflammation.
Similar articles
-
Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients.Am J Hypertens. 2011 Nov;24(11):1194-200. doi: 10.1038/ajh.2011.143. Epub 2011 Aug 11. Am J Hypertens. 2011. PMID: 21833040
-
Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.J Rheumatol. 2003 Oct;30(10):2133-9. J Rheumatol. 2003. PMID: 14528506
-
Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.Scand J Rheumatol. 2008 Sep-Oct;37(5):352-9. doi: 10.1080/03009740802007514. Scand J Rheumatol. 2008. PMID: 18666029
-
Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.J Autoimmun. 2006 Dec;27(4):211-7. doi: 10.1016/j.jaut.2006.09.008. Epub 2006 Nov 7. J Autoimmun. 2006. PMID: 17088047 Review.
-
Cardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review.Phys Sportsmed. 2012 Sep;40(3):43-8. doi: 10.3810/psm.2012.09.1980. Phys Sportsmed. 2012. PMID: 23528620 Review.
Cited by
-
Why are kids with lupus at an increased risk of cardiovascular disease?Pediatr Nephrol. 2016 Jun;31(6):861-83. doi: 10.1007/s00467-015-3202-7. Epub 2015 Sep 23. Pediatr Nephrol. 2016. PMID: 26399239 Review.
-
Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.RMD Open. 2023 Aug;9(3):e003297. doi: 10.1136/rmdopen-2023-003297. RMD Open. 2023. PMID: 37532469 Free PMC article.
-
Efficacy of lifestyle interventions in the management of systemic lupus erythematosus: a systematic review of the literature.Rheumatol Int. 2024 May;44(5):765-778. doi: 10.1007/s00296-024-05548-x. Epub 2024 Mar 7. Rheumatol Int. 2024. PMID: 38451302 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous